Financial information

Sprint Bioscience has been listed on Nasdaq First North Premier since 2014. The company’s share is traded under the name SPRINT. Here we have gathered all financial information relating to the company.

If you have questions, please contact:
Anders Åberg, Chief Executive Officer, Sprint Bioscience
Telephone: +46 (0)8-411 44 55
E-mail: anders.aberg@sprintbioscience.com